Surveillance

Organized Medicine’s Role in Strengthening a Public Health Approach to Overdose Morbidity and Mortality

AMA President, Susan R. Bailey, MD and the AMA Director of Science and Drug Policy, Amy B. Cadwallader, PhD presented a session at the 2021 Rx Drug Abuse & Heroin Summit that highlighted the reasons why data standardization and public health interventions have been elusive and they provide actionable solutions for states, organizations, and policymakers to meaningfully address the nation’s overdose epidemic.

Reports of efforts to help the nation’s overdose epidemic

Updated May 12, 2022

This issue brief is focused on positive interventions from 40 states that are working to help increase access to evidence-based treatment for substance use disorders, patients with pain and harm reduction efforts. The reports include news releases, data from multiple and varied sources, including national, state and local public health agencies, advocacy organizations, law enforcement, emergency medical services, hospitals, treatment centers, research journals and others.

 

America’s drug overdose epidemic: Select 2020-2022 research

Updated May 12, 2022

This issue brief is focused on providing a representative sample of the research published in the past two years focused on substance use disorders, pain and harm reduction. It includes research from medical and scientific journals as well as advocacy organizations. Some of the materials require a subscription while most are publicly available.

Be part of the solution.

Join the AMA today and help us lead the effort
to reverse the nation’s opioid epidemic.